Wasatch Advisors Inc. Increases Stake in LHC Group, Inc. (LHCG)

Wasatch Advisors Inc. lifted its holdings in LHC Group, Inc. (NASDAQ:LHCG) by 17.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 254,381 shares of the health services provider’s stock after purchasing an additional 37,241 shares during the quarter. Wasatch Advisors Inc. owned 1.39% of LHC Group worth $15,581,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in LHCG. Schwab Charles Investment Management Inc. lifted its position in shares of LHC Group by 24.1% in the second quarter. Schwab Charles Investment Management Inc. now owns 104,693 shares of the health services provider’s stock worth $7,108,000 after purchasing an additional 20,355 shares in the last quarter. Legal & General Group Plc lifted its position in shares of LHC Group by 14.9% in the second quarter. Legal & General Group Plc now owns 28,825 shares of the health services provider’s stock worth $1,956,000 after purchasing an additional 3,738 shares in the last quarter. Federated Investors Inc. PA lifted its position in shares of LHC Group by 4.2% in the second quarter. Federated Investors Inc. PA now owns 1,622 shares of the health services provider’s stock worth $110,000 after purchasing an additional 66 shares in the last quarter. Principal Financial Group Inc. increased its holdings in LHC Group by 9.2% during the second quarter. Principal Financial Group Inc. now owns 124,138 shares of the health services provider’s stock worth $8,427,000 after buying an additional 10,431 shares during the last quarter. Finally, Swiss National Bank increased its holdings in LHC Group by 6.7% during the second quarter. Swiss National Bank now owns 27,235 shares of the health services provider’s stock worth $1,849,000 after buying an additional 1,700 shares during the last quarter. 85.41% of the stock is currently owned by institutional investors and hedge funds.

A number of equities analysts recently weighed in on the stock. SunTrust Banks restated a “buy” rating and set a $75.00 target price on shares of LHC Group in a report on Friday, November 3rd. Zacks Investment Research downgraded shares of LHC Group from a “buy” rating to a “hold” rating in a report on Wednesday, October 4th. Oppenheimer boosted their target price on shares of LHC Group from $68.00 to $80.00 and gave the stock an “outperform” rating in a report on Tuesday, November 7th. Craig Hallum restated a “buy” rating and set a $80.00 target price (up from $67.00) on shares of LHC Group in a report on Tuesday, November 7th. Finally, Royal Bank of Canada boosted their target price on shares of LHC Group from $70.00 to $81.00 and gave the stock an “outperform” rating in a report on Tuesday, November 7th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and nine have issued a buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of $77.10.

LHC Group, Inc. (LHCG) opened at $65.86 on Thursday. LHC Group, Inc. has a fifty-two week low of $44.13 and a fifty-two week high of $76.14. The company has a market cap of $1,185.58, a price-to-earnings ratio of 28.39, a price-to-earnings-growth ratio of 1.73 and a beta of 0.70. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.77 and a quick ratio of 1.77.

LHC Group (NASDAQ:LHCG) last released its quarterly earnings data on Monday, November 6th. The health services provider reported $0.64 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.60 by $0.04. LHC Group had a net margin of 4.09% and a return on equity of 9.52%. The firm had revenue of $272.90 million for the quarter, compared to the consensus estimate of $265.35 million. During the same period in the previous year, the company earned $0.54 earnings per share. The company’s quarterly revenue was up 18.2% on a year-over-year basis. equities research analysts predict that LHC Group, Inc. will post 2.4 EPS for the current year.

COPYRIGHT VIOLATION WARNING: This story was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this story on another website, it was copied illegally and republished in violation of US & international copyright law. The original version of this story can be read at https://www.dispatchtribunal.com/2018/01/18/wasatch-advisors-inc-increases-stake-in-lhc-group-inc-lhcg.html.

LHC Group Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply